Related Experiment Video
Updated: Mar 29, 2026

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
Published on: November 10, 2021
The Role of Krüppel-like Factor 4 in Renal Fibrosis
Ben Ke1, Afei Zhang1, Xianfeng Wu1
1Department of Nephrology, Nanchang University School of Medicine, Second Affiliated Hospital to Nanchang University Nanchang, China.
Abstract:
Chronic kidney disease (CKD) caused by renal fibrosis is an important public health concern. It is therefore necessary to understand the molecular pathogenesis of renal fibrosis in order to develop novel therapeutic strategies. KLF4 is the most extensively studied factor among the various members of the Krüppel-like factor (KLF) family of zinc finger-containing transcription factors. Many studies have demonstrated that KLF4 inhibits the activation of myofibroblasts and exerts an inhibitory effect on fibrosis. However, other studies have indicated that KLF4 may promote renal fibrosis. These controversial results suggest that KLF4 may be crucially involved in the development of renal fibrosis, although the underlying mechanism(s) remain unclear. Here, we summarize the recent progress made in understanding the role of KLF4 in renal fibrosis. Together, these findings suggest that KLF4 may participate in the development of renal fibrosis, but that its inhibition of fibrosis is greater than its promotion of the condition, which suggests that KLF4 may serve as a novel therapeutic target for renal fibrosis.
Insights
Krüppel-like factor 4 (KLF4) plays a complex role in kidney fibrosis. While KLF4 can promote fibrosis, its inhibitory effects are stronger, suggesting it could be a therapeutic target for chronic kidney disease.
Area of Science:
- Nephrology
- Molecular Biology
- Cellular Biology
Background:
- Chronic kidney disease (CKD) is a significant public health issue, often driven by renal fibrosis.
- Understanding the molecular mechanisms of renal fibrosis is crucial for developing new treatments.
- Krüppel-like factor 4 (KLF4) is a transcription factor with reported, yet controversial, roles in fibrosis.
Purpose of the Study:
- To review and summarize the current understanding of KLF4's role in the pathogenesis of renal fibrosis.
- To clarify the dual and conflicting roles of KLF4 in the development of kidney fibrosis.
- To evaluate KLF4 as a potential therapeutic target for renal fibrosis.
Main Methods:
- Literature review of studies investigating KLF4 in renal fibrosis.
- Analysis of experimental evidence detailing KLF4's molecular functions in kidney cells.
- Synthesis of findings regarding KLF4's pro-fibrotic and anti-fibrotic activities.
Main Results:
- KLF4 exhibits contradictory effects, with some studies showing it inhibits myofibroblast activation and fibrosis, while others suggest it promotes renal fibrosis.
- Despite promoting fibrosis in certain contexts, KLF4's overall impact appears to be predominantly inhibitory.
- The precise mechanisms underlying KLF4's dual role in renal fibrosis require further elucidation.
Conclusions:
- KLF4 is implicated in the development of renal fibrosis through complex molecular pathways.
- KLF4's antifibrotic effects seem to outweigh its profibrotic actions.
- KLF4 represents a promising therapeutic target for managing renal fibrosis in chronic kidney disease.
More Related Videos
Related Concept Videos
Type IV Collagen of Basal Lamina
A type IV collagen molecule has six alpha chains which can...
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Chronic Kidney Disease I: Introduction
Regulation of Angiogenesis and Blood Supply
Nephrons

